Registration Dossier
Registration Dossier
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 412-570-1 | CAS number: 119462-56-5 PERKALINK 900
Specific investigations: other studies
Administrative data
- Endpoint:
- endocrine system modulation
- Type of information:
- (Q)SAR
- Adequacy of study:
- other information
- Reliability:
- 2 (reliable with restrictions)
- Justification for type of information:
- QSAR prediction
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 014
- Report date:
- 2014
Materials and methods
- Principles of method if other than guideline:
- QSAR assessment for a potential estrogen binding activity via QSAR Toolbox V3.2, EADB database, and ToxCast
- Type of method:
- other: QSAR
Test material
- Reference substance name:
- 1,3-bis(3-methyl-2,5-dioxo-1H-pyrrolinylmethyl)benzene
- EC Number:
- 412-570-1
- EC Name:
- 1,3-bis(3-methyl-2,5-dioxo-1H-pyrrolinylmethyl)benzene
- Cas Number:
- 119462-56-5
- Molecular formula:
- Hill formula: C18 H16 N2 O4
- IUPAC Name:
- 3-methyl-1-({3-[(3-methyl-2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)methyl]phenyl}methyl)-2,5-dihydro-1H-pyrrole-2,5-dione
Constituent 1
Results and discussion
- Details on results:
- An internal QSAR assessment for potential estrogen binding activity via QSAR Toolbox V3.2, EADB database, and ToxCast revealed the substance as non-binder.
Applicant's summary and conclusion
- Executive summary:
An internal QSAR assessment for potential estrogen binding activity via QSAR Toolbox V3.2, EADB database, and ToxCast revealed the substance as non-binder.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
